Damian J. Ralser

969 total citations
35 papers, 325 citations indexed

About

Damian J. Ralser is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Damian J. Ralser has authored 35 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Surgery. Recurrent topics in Damian J. Ralser's work include Cancer-related molecular mechanisms research (5 papers), RNA regulation and disease (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Damian J. Ralser is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), RNA regulation and disease (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Damian J. Ralser collaborates with scholars based in Germany, China and United States. Damian J. Ralser's co-authors include Niklas Klümper, Jörg Ellinger, Glen Kristiansen, Michael Hölzel, Romina Zarbl, Dimo Dietrich, Eva K. Egger, Manuel Ritter, Mateja Condic and Alexander Mustea and has published in prestigious journals such as Journal of Clinical Investigation, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Damian J. Ralser

31 papers receiving 320 citations

Peers

Countries citing papers authored by Damian J. Ralser

Since Specialization

Citations

This map shows the geographic impact of Damian J. Ralser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damian J. Ralser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damian J. Ralser more than expected).

Fields of papers citing papers by Damian J. Ralser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damian J. Ralser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damian J. Ralser. The network helps show where Damian J. Ralser may publish in the future.

Co-authorship network of co-authors of Damian J. Ralser

This figure shows the co-authorship network connecting the top 25 collaborators of Damian J. Ralser. A scholar is included among the top collaborators of Damian J. Ralser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damian J. Ralser. Damian J. Ralser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beneath the surface: delineating the subtypes of Dowling–Degos disease 2025 ·British Journal of Dermatology ·(unknown), Damian J. Ralser, Joerg Wenzel, Jorge Frank, Regina C. Betz	0
2	Figure S1 from The Antibody–Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma 2025 ·Figshare ·(unknown), Niklas Klümper, (unknown), (unknown), Vittorio Branchi, Alexander Semaan, (unknown), (unknown), Susanna S. Ng, Damian J. Ralser, (unknown), Hanno Matthaei, Jörg C. Kalff, (unknown), Veronika Lukacs‐Kornek, Glen Kristiansen, Maria A. González-Carmona, Michael Hölzel, Marieta Toma	0
3	The Antibody–Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma 2025 ·Molecular Cancer Therapeutics ·(unknown), Niklas Klümper, (unknown), (unknown), Vittorio Branchi, Alexander Semaan, (unknown), (unknown), Susanna S. Ng, Damian J. Ralser, (unknown), Hanno Matthaei, Jörg C. Kalff, (unknown), Veronika Lukacs‐Kornek, Glen Kristiansen, Maria A. González-Carmona, Michael Hölzel, Marieta Toma	1
4	High glucose levels promote glycolysis and cholesterol synthesis via ERRα and suppress the autophagy–lysosomal pathway in endometrial cancer 2025 ·Cell Death and Disease ·Xiaodan Mao, Lixiang Huang, Xianhua Liu, (unknown), Qibin Wu, Xinrui Wang, Yuan Ren, (unknown), (unknown), Yao Lin, Damian J. Ralser, Alexander Mustea, Gang Chen, Pengming Sun	2
5	Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery 2024 ·Annals of Surgical Oncology ·Eva K. Egger, (unknown), Tobias Hilbert, Damian J. Ralser, (unknown), Milka Marinova, Matthias B. Stope, Alexander Mustea	0
6	Preclinical evidence for the use of anti‐Trop‐2 antibody‐drug conjugate Sacituzumab govitecan in cerebral metastasized castration‐resistant prostate cancer 2024 ·Cancer Medicine ·(unknown), (unknown), (unknown), (unknown), Damian J. Ralser, Marieta Toma, Glen Kristiansen, Oliver Hahn, Sabrina Zechel, Viktor Grünwald, Tobias Bald, (unknown), Torsten Pietsch, Manuel Ritter, (unknown), Markus Eckstein, (unknown), Philipp Krausewitz, Niklas Klümper	3
7	Clinical comparison of laparoscopic and open surgical approaches for uterus-preserving myomectomy: a retrospective analysis on patient-reported outcome, postoperative morbidity and pregnancy outcomes 2024 ·Archives of Gynecology and Obstetrics ·(unknown), (unknown), (unknown), (unknown), Damian J. Ralser, Eva K. Egger, (unknown)	1
8	Impact of low HER2 expression on response to CDK4/6 inhibitor treatment in advanced HR + /HER2- breast cancer: a multicenter real-world data analysis 2024 ·Archives of Gynecology and Obstetrics ·Damian J. Ralser, (unknown), Erich‐Franz Solomayer, (unknown), Jens‐Uwe Blohmer, (unknown), Nicolaì Maass, Florian Schütz, Cornelia Kolberg‐Liedtke, Carolin Müller, (unknown)	4
9	Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach 2024 ·Journal of Cancer Research and Clinical Oncology ·Alexander Mustea, Damian J. Ralser, Eva K. Egger, (unknown), (unknown), (unknown), David Jackson, Mateja Condic, (unknown), (unknown), Frank Dombrowski, (unknown), Pengming Sun, Anna Laib, (unknown), (unknown), Martin Stein, Dominique Koensgen, Matthias B. Stope	2
10	Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition 2024 ·Lung Cancer ·(unknown), Tobias Bald, Markus Eckstein, Damian J. Ralser, Peter Brossart, Jörg Ellinger, Michael Hölzel, Niklas Klümper	11
11	Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide 2023 ·Cancers ·Alexander Mustea, Damian J. Ralser, Eva K. Egger, (unknown), (unknown), (unknown), David Jackson, Mateja Condic, Christian Meisel, (unknown), Anna Laib, (unknown), (unknown), Martin Stein, Dominique Koensgen, Matthias B. Stope	6
12	The Role of P16, P53, KI-67 and PD-L1 Immunostaining in Primary Vaginal Cancer 2023 ·Cancers ·Eva K. Egger, Mateja Condic, Damian J. Ralser, Milka Marinova, Alexander Mustea, Florian Recker, Glen Kristiansen, Thore Thiesler	1
13	TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target 2023 ·Journal of Cancer Research and Clinical Oncology ·Mateja Condic, Eva K. Egger, Niklas Klümper, Glen Kristiansen, Alexander Mustea, Thore Thiesler, Damian J. Ralser	10
14	Intraoperative Utilization of Indocyanine Green (ICG) Dye for the Assessment of Ovarian Perfusion—Case Report and Review of the Literature 2023 ·Journal of Clinical Medicine ·(unknown), Mateja Condic, Damian J. Ralser, (unknown), Eva K. Egger, (unknown), Alexander Mustea	3
15	CDK4/6 Inhibitors in Advanced HR+/HER2 – Breast Cancer: A Multicenter Real-World Data Analysis 2022 ·Breast Care ·Carolin Müller, (unknown), Erich‐Franz Solomayer, Gudrun Wagenpfeil, (unknown), Jens‐Uwe Blohmer, (unknown), Nicolaì Maass, Florian Schütz, Cornelia Kolberg‐Liedtke, Damian J. Ralser, (unknown)	20
16	N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma 2022 ·BMC Cancer ·Mateja Condic, Thore Thiesler, (unknown), Niklas Klümper, Jörg Ellinger, Eva K. Egger, Kirsten Kübler, Glen Kristiansen, Alexander Mustea, Damian J. Ralser	2
17	Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer 2022 ·Journal of Cancer Research and Clinical Oncology ·Damian J. Ralser, Mateja Condic, Niklas Klümper, Jörg Ellinger, (unknown), Eva K. Egger, Glen Kristiansen, Alexander Mustea, Thore Thiesler	11
18	Postoperative paralytic ileus following debulking surgery in ovarian cancer patients 2022 ·Frontiers in Surgery ·Eva K. Egger, (unknown), Damian J. Ralser, Milka Marinova, Tim O. Vilz, Hanno Matthaei, Tobias Hilbert, Alexander Mustea	3
19	Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report 2021 ·Frontiers in Immunology ·Eva K. Egger, Damian J. Ralser, (unknown), Florian Recker, Milka Marinova, (unknown), (unknown), Alexander Mustea	6
20	Obstetric and Neonatal Outcome of Pregnancy in Carney Complex: A Case Report 2020 ·Frontiers in Endocrinology ·Damian J. Ralser, Brigitte Strizek, Patrick Kupczyk, Birgit Stoffel‐Wagner, (unknown), Andreas Müller, Joachim Woelfle, U. Gembruch, (unknown), Waltraut M. Merz, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact